HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.

Abstract
We describe here, to our knowledge for the first time, associations between polymorphisms at the genomic DNA level in the immunoglobulin gene region and renal diseases which lead to chronic renal failure. Recent studies have shown that protein polymorphisms, present in immunoglobulin (Ig) heavy chains (Gm allotypes) are associated with certain forms of renal disease and with end stage renal failure per se. To investigate this association at the DNA level we have used probes which recognize Ig heavy chain genes and this report describes results obtained with one of these, the S mu switch region probe. With the restriction endonuclease Sst 1 (or the isoschizomer; Sac I) a number of restriction fragment length polymorphisms (RFLP) can be obtained which are recognized by this probe and there is a highly significant association between certain of these and renal disease. This is the first report of Ig switch region polymorphisms being associated with disease, yet our results suggest that S mu RFLP are more closely linked to renal disease than Ig protein polymorphisms.
AuthorsA G Demaine, D H Taube, R W Vaughan, L A Kerr, K I Welsh
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 66 Issue 2 Pg. 406-13 (Nov 1986) ISSN: 0009-9104 [Print] England
PMID2880682 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin Gm Allotypes
  • Immunoglobulin Heavy Chains
Topics
  • Humans
  • Immune System Diseases (genetics, immunology)
  • Immunoglobulin Gm Allotypes (genetics)
  • Immunoglobulin Heavy Chains (genetics)
  • Kidney Diseases (genetics, immunology)
  • Kidney Failure, Chronic (genetics)
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: